Pages that link to "Q67601042"

The following pages link to Morphologic studies for skeletal toxicity after prolonged ciprofloxacin therapy in two juvenile cystic fibrosis patients (Q67601042):

Displaying 16 items.

• Ciprofloxacin in treatment of nosocomial meningitis in neonates and in infants: report of 12 cases and review. (Q33756171) (← links)
• Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics (Q34437719) (← links)
• Intraventricular ciprofloxacin usage in treatment of multidrug-resistant central nervous system infections: report of four cases (Q34930122) (← links)
• Ciprofloxacin safety in paediatrics: a systematic review (Q35161454) (← links)
• Fluoroquinolones in paediatrics: a risk for the patient or for the community? (Q35211282) (← links)
• Musculoskeletal manifestations in cystic fibrosis (Q35561706) (← links)
• Staphylococcal skin infections in children: rational drug therapy recommendations (Q36116435) (← links)
• Effects of ciprofloxacin and ofloxacin on adult human cartilage in vitro (Q39785340) (← links)
• Use of the Quinolones in Paediatrics (Q40489422) (← links)
• Ciprofloxacin after clinical failure of beta-lactam antibiotics in children with salmonellosis (Q40552783) (← links)
• Tolerability of fluoroquinolone antibiotics. Past, present and future (Q40964316) (← links)
• A reappraisal of quinolone tolerability. The experience of their musculoskeletal adverse effects (Q40964323) (← links)
• Fluoroquinolone Therapy in Pediatrics: Where We Stand (Q73628578) (← links)
• Fluoroquinolones in paediatrics (Q73976052) (← links)
• Destruction and loss of bronchial cartilage in cystic fibrosis (Q74099792) (← links)
• Safety of quinolones administration in children? (Q77323810) (← links)